Reduction of hyaluronan-CD44-mediated growth, migration, and cisplatin resistance in head and neck cancer due to inhibition of Rho kinase and PI-3 kinase signaling.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMC 2874205)

Published in Arch Otolaryngol Head Neck Surg on May 01, 2010

Authors

Carlos Torre1, Steven J Wang, Weiliang Xia, Lilly Y W Bourguignon

Author Affiliations

1: Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, San Francisco, CA 94121, USA.

Articles citing this

Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells. Oncogene (2011) 1.67

Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. J Biol Chem (2012) 1.57

Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion. J Biol Chem (2010) 1.56

Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance. Am J Pathol (2011) 1.44

Cooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphoma. Leukemia (2011) 1.04

Inhibition of radiation induced migration of human head and neck squamous cell carcinoma cells by blocking of EGF receptor pathways. BMC Cancer (2011) 0.97

The Role of CD44 in Disease Pathophysiology and Targeted Treatment. Front Immunol (2015) 0.91

Inhibition of hyaluronan synthase-3 decreases subcutaneous colon cancer growth by increasing apoptosis. Anticancer Agents Med Chem (2011) 0.88

The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer. Stem Cells Int (2016) 0.87

Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer. BMC Cancer (2013) 0.83

Silencing of CD44 by siRNA suppressed invasion, migration and adhesion to matrix, but not secretion of MMPs, of cholangiocarcinoma cells. Clin Exp Metastasis (2011) 0.82

Role of moesin in hyaluronan induced cell migration in glioblastoma multiforme. Mol Cancer (2013) 0.81

The Extracellular Matrix in Epithelial Ovarian Cancer - A Piece of a Puzzle. Front Oncol (2015) 0.81

Intratracheal Administration of Hyaluronan-Cisplatin Conjugate Nanoparticles Significantly Attenuates Lung Cancer Growth in Mice. Pharm Res (2016) 0.77

The ability of hyaluronan fragments to reverse the resistance of C6 rat glioma cell line to temozolomide and carmustine. Contemp Oncol (Pozn) (2014) 0.75

xCT expression modulates cisplatin resistance in Tca8113 tongue carcinoma cells. Oncol Lett (2016) 0.75

Kaempferol Inhibits the Invasion and Migration of Renal Cancer Cells through the Downregulation of AKT and FAK Pathways. Int J Med Sci (2017) 0.75

Akt signaling is sustained by a CD44 splice isoform-mediated positive feedback loop. Cancer Res (2017) 0.75

Articles cited by this

Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22

Cancer statistics, 2008. CA Cancer J Clin (2008) 86.74

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med (2007) 10.06

Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway. Cancer Res (2006) 2.17

Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells. J Biol Chem (2006) 2.08

Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression. J Biol Chem (2003) 1.92

Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression. Semin Cancer Biol (2008) 1.91

Regulation of the association of adducin with actin filaments by Rho-associated kinase (Rho-kinase) and myosin phosphatase. J Biol Chem (1998) 1.81

Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death. Int J Cancer (2008) 1.64

A CD44 survival pathway triggers chemoresistance via lyn kinase and phosphoinositide 3-kinase/Akt in colon carcinoma cells. Cancer Res (2001) 1.53

Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth. J Biol Chem (2001) 1.45

Rho-kinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells. Cell Motil Cytoskeleton (1999) 1.45

Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer. Arch Otolaryngol Head Neck Surg (2006) 1.39

Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer. Carcinogenesis (2007) 1.35

AKT involvement in cisplatin chemoresistance of human uterine cancer cells. Gynecol Oncol (2004) 1.22

RhoA and RhoC proteins promote both cell proliferation and cell invasion of human oesophageal squamous cell carcinoma cell lines in vitro and in vivo. Eur J Cancer (2006) 1.20

Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma. Oral Oncol (2005) 1.17

The influence of hyaluronan-CD44 interaction on topoisomerase II activity and etoposide cytotoxicity in head and neck cancer. Arch Otolaryngol Head Neck Surg (2007) 1.04

Hyaluronan-CD44 promotes phospholipase C-mediated Ca2+ signaling and cisplatin resistance in head and neck cancer. Arch Otolaryngol Head Neck Surg (2006) 1.04

Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer. Head Neck (2007) 1.03

CD44v10 interaction with Rho-kinase (ROK) activates inositol 1,4,5-triphosphate (IP3) receptor-mediated Ca2+ signaling during hyaluronan (HA)-induced endothelial cell migration. Cell Motil Cytoskeleton (2002) 1.00

Signaling pathways required for matrix metalloproteinase-9 induction by betacellulin in head-and-neck squamous carcinoma cells. Int J Cancer (2004) 0.97

Small GTP-binding protein, Rho, both increased and decreased cellular motility, activation of matrix metalloproteinase 2 and invasion of human osteosarcoma cells. Jpn J Cancer Res (2001) 0.97

The role of CD44 in HNSCC. Cancer Biol Ther (2007) 0.81

Articles by these authors

Signaling properties of hyaluronan receptors. J Biol Chem (2001) 3.95

Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells. J Biol Chem (2008) 2.42

Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells. J Biol Chem (2009) 2.12

Tumor necrosis factor {alpha} reversibly disrupts the blood-testis barrier and impairs Sertoli-germ cell adhesion in the seminiferous epithelium of adult rat testes. J Endocrinol (2006) 1.66

(-)-gossypol inhibits growth and promotes apoptosis of human head and neck squamous cell carcinoma in vivo. Neoplasia (2006) 1.55

Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells. J Biol Chem (2008) 1.48

Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance. Am J Pathol (2011) 1.44

Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer. Arch Otolaryngol Head Neck Surg (2006) 1.39

CD44 variant isoforms in head and neck squamous cell carcinoma progression. Laryngoscope (2009) 1.37

CD44 interaction with ankyrin and IP3 receptor in lipid rafts promotes hyaluronan-mediated Ca2+ signaling leading to nitric oxide production and endothelial cell adhesion and proliferation. Exp Cell Res (2004) 1.26

Matrix metalloproteinase-9 facilitates glial scar formation in the injured spinal cord. J Neurosci (2008) 1.23

Calcium-induced human keratinocyte differentiation requires src- and fyn-mediated phosphatidylinositol 3-kinase-dependent activation of phospholipase C-gamma1. Mol Biol Cell (2005) 1.23

Dynamin II interacts with the cadherin- and occludin-based protein complexes at the blood-testis barrier in adult rat testes. J Endocrinol (2006) 1.21

Regulation of ectoplasmic specialization dynamics in the seminiferous epithelium by focal adhesion-associated proteins in testosterone-suppressed rat testes. Endocrinology (2004) 1.20

Regulation of Sertoli-germ cell adherens junction dynamics via changes in protein-protein interactions of the N-cadherin-beta-catenin protein complex which are possibly mediated by c-Src and myotubularin-related protein 2: an in vivo study using an androgen suppression model. Endocrinology (2004) 1.10

A mesoporous silica nanoparticle--PEI--fusogenic peptide system for siRNA delivery in cancer therapy. Biomaterials (2012) 1.08

NAD(+) administration decreases ischemic brain damage partially by blocking autophagy in a mouse model of brain ischemia. Neurosci Lett (2012) 1.06

Hyaluronan increases RANKL expression in bone marrow stromal cells through CD44. J Bone Miner Res (2004) 1.04

Hyaluronan-CD44 promotes phospholipase C-mediated Ca2+ signaling and cisplatin resistance in head and neck cancer. Arch Otolaryngol Head Neck Surg (2006) 1.04

Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer. Head Neck (2007) 1.03

The packaging of siRNA within the mesoporous structure of silica nanoparticles. Biomaterials (2011) 1.02

NAD+ metabolism and NAD(+)-dependent enzymes: promising therapeutic targets for neurological diseases. Curr Drug Targets (2012) 1.02

SIRT2 activity is required for the survival of C6 glioma cells. Biochem Biophys Res Commun (2011) 1.01

Adjudin attenuates lipopolysaccharide (LPS)- and ischemia-induced microglial activation. J Neuroimmunol (2012) 1.01

CD44v10 interaction with Rho-kinase (ROK) activates inositol 1,4,5-triphosphate (IP3) receptor-mediated Ca2+ signaling during hyaluronan (HA)-induced endothelial cell migration. Cell Motil Cytoskeleton (2002) 1.00

Downregulation of Fanconi anemia genes in sporadic head and neck squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec (2007) 0.97

Interaction of low molecular weight hyaluronan with CD44 and toll-like receptors promotes the actin filament-associated protein 110-actin binding and MyD88-NFκB signaling leading to proinflammatory cytokine/chemokine production and breast tumor invasion. Cytoskeleton (Hoboken) (2011) 0.96

Electrophysiologic facial nerve monitoring during parotidectomy. Head Neck (2010) 0.96

Restoration of the orbital aesthetic subunit in complex midface defects. Laryngoscope (2004) 0.95

Selective matrix (hyaluronan) interaction with CD44 and RhoGTPase signaling promotes keratinocyte functions and overcomes age-related epidermal dysfunction. J Dermatol Sci (2013) 0.94

Silencing of SIRT2 induces cell death and a decrease in the intracellular ATP level of PC12 cells. Int J Physiol Pathophysiol Pharmacol (2011) 0.93

Magnetic field enhanced cell uptake efficiency of magnetic silica mesoporous nanoparticles. Nanoscale (2012) 0.92

FTY720, a synthetic compound from Isaria sinclairii, inhibits proliferation and induces apoptosis in pancreatic cancer cells. Cancer Lett (2007) 0.91

Oxidative stress and PARP activation mediate the NADH-induced decrease in glioma cell survival. Int J Physiol Pathophysiol Pharmacol (2010) 0.90

TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma. Laryngoscope (2014) 0.89

Tongue reconstruction: recent advances. Curr Opin Otolaryngol Head Neck Surg (2007) 0.89

The β1-integrin-p-FAK-p130Cas-DOCK180-RhoA-vinculin is a novel regulatory protein complex at the apical ectoplasmic specialization in adult rat testes. Spermatogenesis (2011) 0.88

Quality-of-life impact of participation in a head and neck cancer support group. Otolaryngol Head Neck Surg (2007) 0.87

CD38 is a key enzyme for the survival of mouse microglial BV2 cells. Biochem Biophys Res Commun (2012) 0.86

Delivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells. Int J Nanomedicine (2012) 0.86

Male contraceptive Adjudin is a potential anti-cancer drug. Biochem Pharmacol (2012) 0.86

A novel intravital method to evaluate cerebral vasospasm in rat models of subarachnoid hemorrhage: a study with synchrotron radiation angiography. PLoS One (2012) 0.85

Essential role of the electroneutral Na+-HCO3- cotransporter NBCn1 in murine duodenal acid-base balance and colonic mucus layer build-up in vivo. J Physiol (2013) 0.85

The distinct roles of anion transporters Slc26a3 (DRA) and Slc26a6 (PAT-1) in fluid and electrolyte absorption in the murine small intestine. Pflugers Arch (2014) 0.84

Full-thickness skin graft from the groin for coverage of the radial forearm free flap donor site. Am J Otolaryngol (2007) 0.84

Beta2-adrenoceptors and non-beta-adrenoceptors mediate effects of BRL37344 and clenbuterol on glucose uptake in soleus muscle: studies using knockout mice. Br J Pharmacol (2009) 0.84

Perinatal supplementation with omega-3 polyunsaturated fatty acids improves sevoflurane-induced neurodegeneration and memory impairment in neonatal rats. PLoS One (2013) 0.83

Adjudin-mediated junction restructuring in the seminiferous epithelium leads to displacement of soluble guanylate cyclase from adherens junctions. J Cell Physiol (2006) 0.83

Radial forearm free tissue transfer reduces complications in salvage skull base surgery. Otolaryngol Head Neck Surg (2004) 0.83

Regulation of SIRT2 levels for human non-small cell lung cancer therapy. Lung Cancer (2013) 0.83

Role of panendoscopy to identify synchronous second primary malignancies in patients with oral cavity and oropharyngeal squamous cell carcinoma. Head Neck (2010) 0.83

Squamous cell carcinoma of the buccal mucosa: a retrospective analysis of 22 cases. Ear Nose Throat J (2008) 0.83

Diagnosis of Bilateral Tonsil Cancers via Staging PET/CT: Case Report and Review. Int J Otolaryngol (2011) 0.82

Cellular localization of sphingomyelin synthase 2 in the seminiferous epithelium of adult rat testes. J Endocrinol (2007) 0.82

NAD(+) administration significantly attenuates synchrotron radiation X-ray-induced DNA damage and structural alterations of rodent testes. Int J Physiol Pathophysiol Pharmacol (2012) 0.82

Interactions between synchrotron radiation X-ray and biological tissues - theoretical and clinical significance. Int J Physiol Pathophysiol Pharmacol (2011) 0.82

Predictors of quality of life after treatment for oral cavity and oropharyngeal carcinoma. Otolaryngol Head Neck Surg (2008) 0.82

Insights into the mechanism of magnetofection using MNPs-PEI/pDNA/free PEI magnetofectins. Int J Pharm (2011) 0.81

Infrahyoid myocutaneous flap for medium-sized head and neck defects: surgical outcome and technique modification. Otolaryngol Head Neck Surg (2012) 0.81

Roles of oxidative stress in synchrotron radiation X-ray-induced testicular damage of rodents. Int J Physiol Pathophysiol Pharmacol (2012) 0.80

Rab4A GTPase catenin interactions are involved in cell junction dynamics in the testis. J Androl (2007) 0.79

Limited utility of routine surveillance MRI following chemoradiation for advanced-stage oropharynx carcinoma. Int J Otolaryngol (2010) 0.79

Oral tongue squamous cell carcinoma in never-smokers: analysis of clinicopathologic characteristics and survival. Otolaryngol Head Neck Surg (2013) 0.79

Recombinant human erythropoietin pretreatment attenuates acute renal tubular injury against ischemia-reperfusion by restoring transient receptor potential channel-6 expression and function in collecting ducts. Crit Care Med (2014) 0.79

Spinal translocator protein alleviates chronic neuropathic pain behavior and modulates spinal astrocyte-neuronal function in rats with L5 spinal nerve ligation model. Pain (2016) 0.79

Role of Kinase Epidermal Growth Factor Receptor and SRC in the Caerulein-Induced Acute Pancreatitis in Mice. Pancreas (2015) 0.78

New strategies for the prevention of stroke. Clin Exp Pharmacol Physiol (2009) 0.78

Role of hyaluronan synthase 2 to promote CD44-dependent oral cavity squamous cell carcinoma progression. Head Neck (2012) 0.78

The role of CD44 in cutaneous inflammation. Exp Dermatol (2009) 0.78

Improved outcomes in adjuvant radiotherapy for oral cavity carcinoma at an academic center: a matched-pair analysis. Laryngoscope (2014) 0.77

NAD+ treatment induces delayed autophagy in Neuro2a cells partially by increasing oxidative stress. Neurochem Res (2011) 0.77

Image processing tools for alpha-particle track-etch dosimetry. Cancer Biother Radiopharm (2003) 0.77

Recombinant human erythropoietin pretreatment alleviates renal glomerular injury induced by cardiopulmonary bypass by reducing transient receptor potential channel 6-nuclear factor of activated T-cells pathway activation. J Thorac Cardiovasc Surg (2013) 0.77

Differential association of the Na+/H+ Exchanger Regulatory Factor (NHERF) family of adaptor proteins with the raft- and the non-raft brush border membrane fractions of NHE3. Cell Physiol Biochem (2013) 0.77

Towards magnetic-enhanced cellular uptake, MRI and chemotherapeutics delivery by magnetic mesoporous silica nanoparticles. J Nanosci Nanotechnol (2012) 0.77

Oral cavity squamous cell carcinoma in never smokers: analysis of clinicopathologic characteristics and survival. Am J Otolaryngol (2013) 0.77

Cell detection in phase-contrast images used for alpha-particle track-etch dosimetry: a semi-automated approach. Phys Med Biol (2005) 0.76

NAD+ treatment decreases tumor cell survival by inducing oxidative stress. Front Biosci (Elite Ed) (2011) 0.76

NADPH treatment decreases C6 glioma cell survival by increasing oxidative stress. Front Biosci (Elite Ed) (2011) 0.76

Interaction of oligomeric breast cancer resistant protein (BCRP) with adjudin: a male contraceptive with anti-cancer activity. Curr Mol Pharmacol (2014) 0.76

Adjudin disrupts spermatogenesis by targeting drug transporters: Lesson from the breast cancer resistance protein (BCRP). Spermatogenesis (2013) 0.76

Rare complication after thyroidectomy-cervical esophageal stenosis: a case report and literature review. World J Surg Oncol (2014) 0.75

Identifying and improving knowledge deficits of emergency airway management of tracheotomy and laryngectomy patients: a pilot patient safety initiative. Int J Otolaryngol (2010) 0.75

Effective Delivery of Male Contraceptives Behind the Blood-Testis Barrier (BTB) - Lesson from Adjudin. Curr Med Chem (2016) 0.75

Iatrogenic bilateral inverted papilloma: case report and literature review. J Otolaryngol (2007) 0.75

Binary methods for the microdosimetric analysis of cell survival data from alpha-particle irradiation. Cancer Biother Radiopharm (2003) 0.75

Stepwise regional and distant progression of recurrent pleomorphic adenoma. J Otolaryngol Head Neck Surg (2011) 0.75

Simulation of binary methods for the microdosimetric analysis of cell survival after alpha-particle irradiation: ability to distinguish between different models. Radiat Res (2004) 0.75

Combined modality treatment outcomes for head and neck cancer: comparison of postoperative radiation therapy at academic vs nonacademic medical centers. JAMA Otolaryngol Head Neck Surg (2013) 0.75

Management of advanced nodal disease following chemoradiation for head and neck squamous cell carcinoma: role of magnetic resonance imaging. J Otolaryngol (2007) 0.75

The Limitations of Routine Magnetic Resonance Imaging for Long-Term Post-Treatment Locoregional Surveillance of Salivary Carcinoma. ORL J Otorhinolaryngol Relat Spec (2015) 0.75

Minicricothyrotomy approach with fiberoptic guidance for management of posterior glottic stenosis. Laryngoscope (2007) 0.75

Adjudin - A Male Contraceptive with Other Biological Activities. Recent Pat Endocr Metab Immune Drug Discov (2015) 0.75